Home / Bio-technology / United States Synthetic Biology Market Report 2016

United States Synthetic Biology Market Report 2016

  • Id : RNR-25317
  • Category : Bio-technology
  • Publish Date : 13-Oct
  • Pages : 117
  • Format : PDF
License Type

Description
Notes:
Sales, means the sales volume of Synthetic Biology
Revenue, means the sales value of Synthetic Biology

This report studies sales (consumption) of Synthetic Biology in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
    Amyris, Inc. (U.S.)
    DuPont (U.S.)
    GenScript USA Inc. (U.S.)
    Intrexon Corporation (U.S.)
    Integrated DNA Technologies (IDT) (U.S.)
    New England Biolabs, Inc. (NEB) (U.S.)
    Novozymes (Denmark)
    Royal DSM (Netherlands)
    Synthetic Genomics, Inc. (California)
    Thermo Fisher Scientific, Inc. (U.S.)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
    Xeno-nucleic Acids (XNA)
    Oligonucleotides
    Chassis Organisms
    Enzymes
    Cloning and Assembly kits
Split by applications, this report focuses on sales, market share and growth rate of  Synthetic Biology in each application, can be divided into
    Environmental Application
    Medical Application
    Industrial Application